title: Lamivudine for the prevention of hepatitis B virus reactivation during autologous stem cell transplantation. A case report.
authors.forename: F
authors.initials: F
authors.lastname: Silvestri
authors.forename: A
authors.initials: A
authors.lastname: Sperotto
authors.forename: A
authors.initials: A
authors.lastname: Ermacora
authors.forename: R
authors.initials: R
authors.lastname: Fanin
authors.forename: D
authors.initials: D
authors.lastname: Damiani
authors.forename: M
authors.initials: M
authors.lastname: Baccarani
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D018380:Hematopoietic Stem Cell Transplantation; D006509:Hepatitis B / Q000175:diagnosis / Q000517:prevention & control; D006515:Hepatitis B virus / Q000502:physiology*; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use*; D008297:Male; D014182:Transplantation, Autologous; D014775:Virus Activation / Q000187:drug effects*
chemical_list: D000998:Antiviral Agents; D019259:Lamivudine